563 A NOVEL RECOMBINANT FORM OF THE HUMAN MANGANESE SUPEROXIDE DISMUTASE PROTECTS RAT LIVER GRAFTS PROCURED FOR TRANSPLANTATION

2013 ◽  
Vol 58 ◽  
pp. S231-S232 ◽  
Author(s):  
D. Hide ◽  
S. Guixé-Muntet ◽  
A. Mancini ◽  
J. Bosch ◽  
J. Gracia- Sancho
2016 ◽  
Vol 2016 ◽  
pp. 1-4
Author(s):  
Lucia Grumetto ◽  
Antonio Del Prete ◽  
Giovanni Ortosecco ◽  
Antonella Borrelli ◽  
Salvatore Del Prete ◽  
...  

Background. We report a case of bilateral posterior subcapsular cataracts (PSCs) in a 24-year-old man with an allergic conjunctivitis history caused by a long-term therapy with glucocorticoids.Case Presentation. The patient showed a visual acuity of 9/10 for both eyes. He followed a therapy with ketotifen and bilastine for four years. During the last six months before our evaluation, he was treated with chloramphenicol and betamethasone, interrupted for onset of cataracts and increased intraocular pressure. We treated him with ophthalmic gel preparation containing a new recombinant form of manganese superoxide dismutase (rMnSOD) at a concentration of 12.5 μg/mL, only for the right eye, while left eye was treated with standard protocol of Bendazac-lysine g 0.5.Conclusion. This case report shows the protective effects of rMnSOD versus PSC disease, probably due to the capacity of rMnSOD of countering free radical species.


1996 ◽  
Vol 220 (3) ◽  
pp. 546-552 ◽  
Author(s):  
Silvia Borrello ◽  
Maria Emilia De Leo ◽  
Matteo Landriscina ◽  
Bernardetta Palazzotti ◽  
Tommaso Galeotti

2005 ◽  
Vol 186 (3) ◽  
pp. 539-547 ◽  
Author(s):  
Virginia Fernández ◽  
Gladys Tapia ◽  
Patricia Varela ◽  
Iván Castillo ◽  
Catalina Mora ◽  
...  

Recently, we demonstrated that 3,3′,5-triiodothyronine (T3) induces oxidative stress in rat liver, with enhancement in the DNA binding of nuclear factor-κB (NF-κB) and the NF-κB-dependent expression of tumor necrosis factor-α (TNF-α). In this study, we show that T3 administration (daily doses of 0.1 mg/kg i.p. for three consecutive days) elicited a calorigenic response and higher liver O2 consumption rates, with increased serum levels of TNF-α (ELISA), liver inhibitor of κB (IκB-α) phosphorylation (Western blot analysis), and hepatic NF-κB DNA binding (EMSA) at 56–72 h after treatment. Within this time interval, liver manganese superoxide dismutase (MnSOD) activity and the protein expression of MnSOD and Bcl-2 are enhanced. These changes are abrogated by the administration of α-tocopherol (100 mg/kg i.p.) prior to T3. It is concluded that T3 treatment leads to the redox upregulation of MnSOD and Bcl-2 in rat liver, in association with TNF-α release and activation of the IκB-α kinase/NF-κB cascade, which may constitute a protective mechanism against free radical toxicity involving cell death signaling.


Sign in / Sign up

Export Citation Format

Share Document